Tesa-IpaTesa-Ipa is a two-component laboratory blend supplied in a single vial containing Tesamorelin 12mg and Ipamorelin 6mg. Tesamorelin is a synthetic analog of human GHRH(1-44) bearing an N-terminal hexenoyl modification studied for the resistance it confers to enzymatic cleavage; Ipamorelin is a synthetic pentapeptide characterized as a selective agonist at the GHS-R1a (ghrelin) receptor. Because the two peptides bind unrelated receptor families, the blend is supplied as a paired reference material for in vitro receptor-binding and receptor-selectivity panels, cAMP and calcium-flux assays in transfected cell lines, and chromatographic separation, identity, and purity work by HPLC and LC-MS/MS. For research and laboratory use only; not for human or animal consumption.

Tesa-Ipa is a laboratory blend of two structurally distinct synthetic peptides, Tesamorelin and Ipamorelin, supplied together in a single vial for comparative in vitro work across two separate receptor targets.

Tesamorelin is a synthetic analog of human GHRH(1-44) modified with an N-terminal hexenoyl group. That modification is the subject of serum-stability and degradation assays, where it is studied for the resistance it confers to enzymatic cleavage relative to the unmodified sequence. In receptor pharmacology Tesamorelin is characterized as an agonist at the GHRH receptor, a class B G-protein-coupled receptor, and is used in vitro as a ligand for GHRH-receptor binding affinity measurements and cAMP accumulation assays in transfected cell lines.

Ipamorelin is a synthetic pentapeptide characterized as a selective agonist at the ghrelin receptor GHS-R1a. In comparative in vitro binding panels it is noted for selectivity toward GHS-R1a over other pituitary-expressed receptor targets, which makes it a useful reference ligand when profiling receptor cross-reactivity and assay specificity.

Because the two peptides engage unrelated receptor families, the blend is used in laboratory settings as a paired reference material for receptor-selectivity panels, radioligand and fluorescence-polarization binding assays, calcium-flux and cAMP readouts, and reversed-phase HPLC or LC-MS/MS separation, identity confirmation, and purity determination of the two components.

Tesamorelin: 12mg

Ipamorelin: 6mg

Disclaimer: Tesa-Ipa is supplied strictly for research and laboratory use only. This product is not a drug, dietary supplement, or medical device. It is not intended for human or animal consumption, and not for therapeutic, diagnostic, or clinical application. It has not been evaluated by the FDA, and no statement here should be read as a claim to diagnose, treat, cure, or prevent any condition. All handling should be performed by qualified researchers in accordance with applicable laboratory safety protocols and institutional guidelines.